
Feinberg scientists including the lab of William Muller, MD, PhD, are investigating how regulating inflammation can be a pathway to treating a range of diseases.

A new Northwestern study has discovered a technique to help make immunomodulation more effective, potentially improving treatment for type 1 diabetes.

A Northwestern Medicine study has found that a new combination immune therapy treatment not only extended cancer patients’ lives better than other treatments, it also was less toxic to their overall health than other drugs on the market.

Jane Winter, MD, a highly regarded lymphoma expert, will serve as president of the American Society of Hematology for a year-long term through December 2022.

A new Northwestern Medicine study reports that DNA manifested as knot-like folds and third rungs between DNA’s two strands may drive cancer development and an important regulatory enzyme could be associated with the formation of these unusual structures.

Northwestern University Feinberg School of Medicine has established the Potocsnak Longevity Institute, an ambitious multi-center institute, with the goal of rapidly advancing the science of aging.

Northwestern Medicine investigators have discovered the molecular mechanisms underlying a rare genetic disorder that increases the risk of severe liver disease, according to a recent study.

Feinberg experienced a year of exceptional growth, perseverance, and collaboration in 2021, from honors and awards to unprecedented research discoveries.

A new Northwestern Medicine study has, for the first time, derived and validated a set of risk prediction models for lifetime risk of heart failure.

Steven DeVries, MD, PhD, has received a $75,000 International Research Collaborators Award from Research to Prevent Blindness to support international collaborations.